Home > Investors

Investors

Latest Updates

Analyst Coverage

20220713_First Shanghai Securities: The leader of EBD equipment on the fast lane of non-surgical medical aesthetics; Initiating with Buy

Jul 18, 2022
Analyst Coverage

20220713_Eastmoney Securities: Product iteration + channel adjustment, EBD leader achieves global presence; Initiating with Buy

Jul 18, 2022
Analyst Coverage

20220628_ Sinolink Securities: Phase IIb clinical result on submental fat reduction has reached its primary endpoint, the volume of submental fat of the clinical trial participants was reduced by 15% on average

Jul 18, 2022
Press Release

Sisram Medical’s associate company Tianjin JuveStar released Phase IIb result of lipolysis injection, reduction of submental fat by 15% through one treatment

Jun 28, 2022
Press Release

LMNT, Sisram Medical's Home-use Brand, is Officially Launching in China

May 10, 2022
Press Release

Alma, a Sisram Medical Company, Announces the Launch of Alma TED™ and the Company’s Professional Skincare Line...

Mar 25, 2022
Presentation

2021 Annual Results Investors Presentation

Mar 16, 2022

Financial Reports

View all

26.04.22
2021 Annual Report
01.01.21
2021 Interim Report

52 week Range -

/

Prospectus

Investors’ Relations Contacts

Sisram Medical LTD.

Email: [email protected]

OFEK 15 Building, 18 HaHarash Street, Industrial Park- Caesarea, 3079895, Israel